ADRA2A and IRX1 are putative risk genes for Raynaud's phenomenon (2022)
Attributed to:
Phase 1 COVID-19 Longitudinal Health and Wellbeing - National Core Study
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2022.10.19.22281276
Publication URI: http://dx.doi.org/10.1101/2022.10.19.22281276
Type: Preprint